相关实验视频
Updated: May 21, 2025

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.2K
在异构血造干细胞移植中生存率的评估
1St George Hospital, Centre for Research in Nursing and Health, Kogarah, NSW, Australia. gmcerlean@uow.edu.au.
Methods in molecular biology (Clifton, N.J.)
|March 18, 2025
概括
全基性造血干细胞移植 (allo-HSCT) 提供了拯救生命的好处,但由于二次癌症和慢性疾病的风险增加,需要对幸存者进行终身监测. 更新的指导方针侧重于查和预防护理,以尽量减少长期影响.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 全源性造血干细胞移植 (allo-HSCT) 是对成人和儿童各种癌症和疾病的关键治疗方法.
- 虽然alo-HSCT显著提高了以前绝症的生存率,但幸存者面临着长期和晚期的重大影响.
- 这些晚期影响包括二次癌症,感染,移植与宿主疾病 (GVHD) 和慢性疾病的风险增加,影响生活质量.
研究的目的:
- 提供allo-HSCT对幸存者健康的长期影响的概述.
- 概述2023年更新的国际推对所有HSCT幸存者的查和预防实践.
- 强调终身监测和定制护理的重要性,以减轻晚期影响.
主要方法:
- 综述现有关于alo-HSCT的长期和晚期影响的文献.
- 分析国际和国家关于幸存者护理的共识指南.
- 对查,疫苗接种和预防策略的最新建议的综合.
主要成果:
- 与对照组相比,allo-HSCT幸存者经历的医疗问题负担更高,包括可以预防的疾病.
- 幸存者有明显增加的严重/危及生命的条件的风险,特别是那些与GVHD.
- 国际指导方针建议进行全面的长期随访,包括健康咨询,预防护理和癌症查.
结论:
- 终身监测和遵守最新的查和预防指南对于所有HSCT幸存者至关重要.
- 晚期影响的积极管理可以优化幸存者的结果并改善生活质量.
- 2023年的建议旨在标准化和加强对这种不断增长的移植幸存者群体的护理.
相关概念视频
Bone Marrow Sampling and Transplants
268
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
268
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K

